Partema medicus - Company finances
|
EUR
|
2020
From: 2020-11-03
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | - | 37,969 | 165,331 | 181,935 | 447,861 | 807,798 |
| Profit before tax | -90 | -18,102 | 29,450 | 24,711 | 35,776 | 108,408 |
| Net profit | -90 | -18,102 | 28,897 | 23,583 | 32,195 | 91,634 |
| Equity | 2,410 | -15,692 | 13,205 | 36,788 | 68,982 | 110,617 |
| Liabilities | 0 | 84,782 | 78,815 | 78,561 | 51,190 | 231,236 |
| Non-current assets | 0 | 12,605 | 16,968 | 48,265 | 57,078 | 65,284 |
| Current assets | 2,410 | 56,001 | 74,790 | 65,684 | 62,539 | 274,854 |
| Total assets | 2,410 | 68,606 | 91,758 | 113,949 | 119,617 | 340,138 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | +335.4% | +10.0% | +146.2% | +80.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -3.7% | -26.4% | 31.5% | 20.7% | 26.9% | 26.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -3.7% | - | 218.8% | 64.1% | 46.7% | 82.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -47.7% | 17.5% | 13.0% | 7.2% | 11.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -47.7% | 17.8% | 13.6% | 8.0% | 13.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 6.0 | 2.1 | 0.7 | 2.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 32,544 | 165,331 | 181,935 | 447,861 | 807,798 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Partema medicus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-03-16 | 2023-03-21 | 146.16 |
| 2023-01-17 | 2023-01-18 | 71.60 |
Partema medicus - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-19 | 2025-06-23 | 0.22 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Partema medicus, UAB (code 305651982) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the latest financial year, the company generated revenue of €807.8K and net profit of €91.6K, giving a profit margin of 11.3%. Revenue increased by 80.4% year on year and by 344.0% over two years, showing a strong expansion trend. Profit also improved over the period, rising from €23.6K in 2023 to €32.2K in 2024 and €91.6K in 2025. The balance sheet expanded materially in 2025, with total assets of €340.1K, equity of €110.6K and liabilities of €231.2K. Short-term assets of €274.9K dominated the asset base, while long-term assets stood at €65.3K. Key ratios indicate solid operating efficiency, with return on equity at 82.8%, return on assets at 26.9%, debt-to-equity at 2.09, and asset turnover at 2.37x. Revenue per employee in 2025 was €807.8K, while profit per employee was €91.6K.